Hudson Bay Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Buy	535,730 +110,730	+26%	+$428K	0.01%	801
2025 Q4	$1.74M	Buy	425,000 +200,000	+89%	+$991K	0.01%	732
2025 Q3	$1.1M	Buy	225,000 +75,000	+50%	+$394K	0.01%	850
2025 Q2	$759K	Buy	150,000 +22,930	+18%	+$113K	0.01%	1006
2025 Q1	$672K	Buy	127,070 +49,570	+64%	+$361K	﹤0.01%	988
2024 Q4	$524K	Sell	77,500 -12,500	-14%	-$84K	﹤0.01%	807
2024 Q3	$593K	Buy	90,000 +45,000	+100%	+$323K	﹤0.01%	715
2024 Q2	$338K	Buy	45,000 +15,000	+50%	+$131K	﹤0.01%	653
2024 Q1	$299K	Sell	30,000 -50,000	-63%	-$557K	﹤0.01%	594
2023 Q4	$789K	Buy	80,000 +40,000	+100%	+$285K	0.01%	536
2023 Q3	$306K	Sell	40,000 -70,000	-64%	-$698K	﹤0.01%	615
2023 Q2	$822K	Buy	+110,000	New	+$770K	0.01%	611
2022 Q3	–	Sell	-120,000	Closed	-$977K	–	1355
2022 Q2	$977K	Sell	120,000 -80,000	-40%	-$535K	0.01%	939
2022 Q1	$1.43M	Buy	+200,000	New	+$2.13M	0.02%	782